Results 341 to 350 of about 5,889,184 (390)
Travel Time to Treating Facility and Mortality in Men With Prostate Cancer.
JAMA Netw OpenKorn SM +13 more
europepmc +1 more source
Ca-A Cancer Journal for Clinicians, 2021 This article provides an update on the global cancer burden using the GLOBOCAN 2020 estimates of cancer incidence and mortality produced by the International Agency for Research on Cancer.
Hyuna Sung +2 more
exaly +2 more sources
Ca-A Cancer Journal for Clinicians, 2023 Each year, the American Cancer Society estimates the numbers of new cancer cases and deaths in the United States and compiles the most recent data on population‐based cancer occurrence and outcomes using incidence data collected by central cancer ...
Rebecca L Siegel +2 more
exaly +2 more sources
Ca-A Cancer Journal for Clinicians, 2022 Each year, the American Cancer Society estimates the numbers of new cancer cases and deaths in the United States and compiles the most recent data on population‐based cancer occurrence and outcomes.
Rebecca L Siegel +2 more
exaly +2 more sources
Ca-A Cancer Journal for Clinicians, 2021 Each year, the American Cancer Society estimates the numbers of new cancer cases and deaths in the United States and compiles the most recent data on population‐based cancer occurrence.
Rebecca L Siegel, Kimberly D Miller
exaly +2 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Current Opinion in Oncology, 1997
Prostate cancer accounted for over 41,000 deaths in the United States in 1996. Prostate-specific antigen (PSA) screening is capable of detecting prostate cancer and appears to detect cancers that are both clinically significant as well as organ-confined, and therefore potentially curable. The positive predictive value of PSA value has been increased by
L, Balducci +3 more
+7 more sources
Prostate cancer accounted for over 41,000 deaths in the United States in 1996. Prostate-specific antigen (PSA) screening is capable of detecting prostate cancer and appears to detect cancers that are both clinically significant as well as organ-confined, and therefore potentially curable. The positive predictive value of PSA value has been increased by
L, Balducci +3 more
+7 more sources
Endocrinology and Metabolism Clinics of North America, 1994
Prostate carcinoma is a growing concern in our aging society. While the disease often follows a indolent course, it is the second leading cause of cancer-related deaths in males. Prostate cancer screening is promising but remains unproven and controversial. The therapy of prostate cancer has changed little over the past 10 years.
W J, Ellis, P H, Lange
+7 more sources
Prostate carcinoma is a growing concern in our aging society. While the disease often follows a indolent course, it is the second leading cause of cancer-related deaths in males. Prostate cancer screening is promising but remains unproven and controversial. The therapy of prostate cancer has changed little over the past 10 years.
W J, Ellis, P H, Lange
+7 more sources